Table 4 Antimicrobial susceptibility testing results in blood and CSF of A. baumannii, P. aeruginosa, E. coli, K. pneumoniae, Enterobacter spp., E. faecium, S. aureus, S. pneumoniae and H. influenzae; in stool for Salmonella spp. and Shigella spp. of 13 hospitals in VINARES 2016–2017 project. Denominators and numerators are the numbers of tested and resistant isolates respectively. Corresponding resistant percentages are in brackets
From: Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016–2017
E. coli (N = 1535) | K. pneumoniae (N = 482) | A. baumannii (N = 187) | P. aeruginosa (N = 142) | Enterobacter spp. (N = 77) | Shigella spp. (N = 37)** | Salmonella spp. (N = 32)** | H. influenzae (N = 12) | |
|---|---|---|---|---|---|---|---|---|
Carbapenem | 116/1483 (8%) | 109/476 (23%) | 110/183 (60%) | 54/139 (39%) | 20/77 (26%) | 1/14 (7%) | 0/19 (0%) | 0/11 (0%) |
Aminoglycosides | 637/1471 (43%) | 195/470 (41%) | 107/185 (58%) | 48/138 (35%) | 35/75 (47%) | |||
Fluoroquinolones | 953/1475 (65%) | 177/459 (39%) | 96/182 (53%) | 37/138 (27%) | 24/76 (32%) | 4/31 (13%) | 3/27 (11%) | 0/9 (0%) |
Cephalosporins | 931/1402 (66%) | 221/471 (47%) | 118/178 (66%) | 47/120 (39%) | 37/66 (56%) | 7/21 (33%) | 4/28 (14%) | 0/11 (0%) |
Macrolides | 1/1 (100%) | 2/3 (67%) | 1/5 (20%) | 0/4 (0%) | ||||
SXT | 935/1377 (68%) | 215/454 (47%) | 74/82 (90%) | 29/57 (51%) | 31/34 (91%) | 6/30 (20%) | 5/8 (62%) | |
AMC | 180/577 (31%) | 112/285 (39%) | 26/32 (81%) | 1/5 (20%) | ||||
Ampicillin | 928/1028 (90%) | 278/287 (97%) | 21/23 (91%) | 23/33 (70%) | 14/31 (45%) | 7/8 (88%) | ||
TCC | 169/356 (47%) | 115/195 (59%) | 46/110 (42%) | 14/45 (31%) |